Esperion Therapeutics, Inc. · NASDAQ:ESPR
Esperion Therapeutics, Inc. shareholders
As of Jun 30, 2026, 188 institutions reported holding Esperion Therapeutics, Inc. Largest: Glazer Capital, LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Esperion Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Glazer Capital, LLC | 22.4M | new | Aug 17, 2026 | |
| BlackRock | 22.1M | +4.28M | Aug 7, 2026 | |
| Vanguard | 15.7M | +53,236 | Aug 13, 2026 | |
| Trium Capital LLP | 11.2M | new | Jul 16, 2026 | |
| Goldman Sachs | 10.4M | +7.97M | Aug 14, 2026 | |
| State Street | 7.28M | +220K | Aug 7, 2026 | |
| Two Sigma | 7.13M | −2.33M | Aug 14, 2026 | |
| Geode Capital | 6.63M | +674K | Aug 12, 2026 | |
| AQR Arbitrage LLC | 6.05M | new | Aug 14, 2026 | |
| Oddo Bhf Asset Management Sas | 5M | new | Aug 13, 2026 |